Endocannabinoid System Clinical Research: 2024 RCT Finds
A 2024 randomized controlled trial evaluated digital mental health interventions using the Minder mobile app designed for university students. The study assessed improvements in mental health and substance use outcomes during a critical transition…
Endocannabinoid System Clinical Research: REAL 2.0 Study Overview
The endocannabinoid system adolescent mental health research from the REAL 2.0 study tracks youth over 15 years to understand eating disorders and substance use. This research highlights how adolescent body image and disordered eating predict adult…
Endocannabinoid System Clinical Research: Minder RCT Insights
This article reviews endocannabinoid system clinical research RCT findings from the Minder app trial. The study evaluated digital interventions for mental health and substance use in university students. Results highlight the app's potential to improve…
Cannabinoid Clinical Trials: Cannabis in Student Mental Health
This randomized controlled trial evaluates a digital mental health intervention students can access during the critical university transition. The study focuses on cannabis and other substance use alongside mental health outcomes. Results highlight the…
Endocannabinoid System Research: Trauma, Sleep & Cannabis Use
Pre-trauma insomnia substance use risk is a significant factor in predicting alcohol and cannabis use following trauma. This research highlights the importance of screening for sleep disturbances in trauma survivors. Addressing pre-trauma insomnia…
Endocannabinoid System & Adolescent Health: 15-Year REAL 2.0 Study
This 15-year REAL 2.0 study highlights endocannabinoid system adolescent health research focusing on eating disorders and mental health outcomes. It tracks youth into adulthood to understand psychosocial risk factors. The findings emphasize early…
Endocannabinoid System & Trauma Sleep Research Findings
Pre-trauma insomnia posttraumatic alcohol cannabis use are closely linked in trauma survivors. This focus keyword highlights the risk of substance use following sleep disturbances before trauma. Clinicians should screen for insomnia to reduce…
Endocannabinoid System Clinical Research: Eating & Weight Insights
This article highlights endocannabinoid system adolescent weight research focusing on how early body image and eating patterns predict adult health outcomes. The study underscores the importance of early screening for disordered eating in adolescents.…
Endocannabinoid System & Teen Anxiety: Clinical Evidence
Internalising symptoms adolescent cannabis use is linked to increased risk of initiation and escalation among teens. This clinical evidence highlights the importance of screening for anxiety and depression in adolescents. Understanding these risks can…
Understanding the Risk of Psychiatric Disorders from Adolescent Cannabis Use
Adolescent cannabis psychiatric disorders risk includes increased chances of psychotic, bipolar, depressive, and anxiety disorders. This risk is supported by large population-level clinical data. Understanding this risk helps guide adolescent mental…